Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Nature Communications|April 27, 2026
Histone methylation defines c-Jun/Sox2/Hif1α axis that controls stemness and tumor progression in squamous cell carcinomaDarshan Mehta, Akshay Paradkar, Bharat Rekhi, et al.
Pathologica|November 17, 2025
Lymphoepithelioma-like carcinoma of urinary bladder - a rare subtype of urothelial carcinoma: a series of 12 casesRutvij Khedkar, Ramandeep Kaur, Swapnil Rane, et al.
Scientific Reports|January 8, 2025
Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCRDuhita Mirikar, Nandini Banerjee, Kumar Prabhash, et al.
Scientific Reports|August 25, 2022
Prevention of carcinogen-induced oral cancers by polymeric black tea polyphenols via modulation of EGFR-Akt-mTOR pathwayVaishnavi K Nimbalkar, Jeet Gangar, Saptarsi Shai, et al.
The Journal of Pathology|August 14, 2023
Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospectsGregory Verghese, Jochen K Lennerz, Danny Ruta, et al.
British Journal of Cancer|September 17, 2020
Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumabUsha Patel, Manish Pandey, Sadhana Kannan, et al.
Cancers|March 28, 2024
Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT ImagingAbhishek Mahajan, Vatsal Kania, Ujjwal Agarwal, et al.
Oral Oncology|April 5, 2026
Diagnostic value of MRI-based iENE assessment for predicting major and minor extranodal extension in oral tongue carcinomaNivedita Chakrabarty, Tapish Dadlani, Abhishek Mahajan, et al.
Human Cell|December 18, 2025
Generation and characterization of early stage oral cancer cell line of buccal mucosa of Indian originAkhila George, Sudhir Nair, Kumar Prabhash, et al.
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
Pageof 7